GRCE

Grace Therapeutics (GRCE)

About Grace Therapeutics (GRCE)

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Details

Daily high

$2.35

Daily low

$2.22

Price at open

$2.26

52 Week High

$5.18

52 Week Low

$1.79

Market cap

36.2M

Dividend yield

0.00%

Volume

6,241

Avg. volume

1.2M

P/E ratio

-6.49

Grace Therapeutics News